Skip to main content
PMC home page
Journal of Virology logoLink to Journal of Virology
. 1997 Nov;71(11):8377–8384. doi: 10.1128/jvi.71.11.8377-8384.1997

Regulation of receptor binding affinity of influenza virus hemagglutinin by its carbohydrate moiety.

M Ohuchi 1, R Ohuchi 1, A Feldmann 1, H D Klenk 1
PMCID: PMC192299  PMID: 9343193

Abstract

The hemagglutinin (HA) of the fowl plague virus (FPV) strain of influenza A virus has two N-linked oligosaccharides attached to Asn123 and Asn149 in the vicinity of the receptor binding site. The effect of these carbohydrate side chains on the binding of HA to neuraminic acid-containing receptors has been analyzed. When the oligosaccharides were deleted by site-specific mutagenesis, HA expressed from a simian virus 40 vector showed enhanced hemadsorbing activity. Binding was so strong under these conditions that erythrocytes were no longer released by viral neuraminidase and that release was significantly reduced when neuraminidase from Vibrio cholerae was used. Similarly, when these oligosaccharides were removed selectively from purified viruses by N-glycosidase F, such virions were unable to elute from receptors, although they retained neuraminidase activity. Thus, release of FPV from cell receptors depends on the presence of the HA glycans at Asn123 and Asn149. On the other hand, receptor binding was abolished when these oligosaccharides were sialylated after expression in the absence of neuraminidase (M. Ohuchi, A. Feldmann, R. Ohuchi, and H.-D. Klenk, Virology 212:77-83, 1995). These observations indicate that the receptor affinity of FPV HA is controlled by oligosaccharides adjacent to the receptor binding site.

Full Text

The Full Text of this article is available as a PDF (728.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aytay S., Schulze I. T. Single amino acid substitutions in the hemagglutinin can alter the host range and receptor binding properties of H1 strains of influenza A virus. J Virol. 1991 Jun;65(6):3022–3028. doi: 10.1128/jvi.65.6.3022-3028.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bulleid N. J., Bassel-Duby R. S., Freedman R. B., Sambrook J. F., Gething M. J. Cell-free synthesis of enzymically active tissue-type plasminogen activator. Protein folding determines the extent of N-linked glycosylation. Biochem J. 1992 Aug 15;286(Pt 1):275–280. doi: 10.1042/bj2860275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bullough P. A., Hughson F. M., Skehel J. J., Wiley D. C. Structure of influenza haemagglutinin at the pH of membrane fusion. Nature. 1994 Sep 1;371(6492):37–43. doi: 10.1038/371037a0. [DOI] [PubMed] [Google Scholar]
  4. Cebon J., Nicola N., Ward M., Gardner I., Dempsey P., Layton J., Dührsen U., Burgess A. W., Nice E., Morstyn G. Granulocyte-macrophage colony stimulating factor from human lymphocytes. The effect of glycosylation on receptor binding and biological activity. J Biol Chem. 1990 Mar 15;265(8):4483–4491. [PubMed] [Google Scholar]
  5. Günther I., Glatthaar B., Döller G., Garten W. A H1 hemagglutinin of a human influenza A virus with a carbohydrate-modulated receptor binding site and an unusual cleavage site. Virus Res. 1993 Feb;27(2):147–160. doi: 10.1016/0168-1702(93)90078-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hansen L., Blue Y., Barone K., Collen D., Larsen G. R. Functional effects of asparagine-linked oligosaccharide on natural and variant human tissue-type plasminogen activator. J Biol Chem. 1988 Oct 25;263(30):15713–15719. [PubMed] [Google Scholar]
  7. Howard S. C., Wittwer A. J., Welply J. K. Oligosaccharides at each glycosylation site make structure-dependent contributions to biological properties of human tissue plasminogen activator. Glycobiology. 1991 Sep;1(4):411–418. doi: 10.1093/glycob/1.4.411. [DOI] [PubMed] [Google Scholar]
  8. Katz J. M., Wang M., Webster R. G. Direct sequencing of the HA gene of influenza (H3N2) virus in original clinical samples reveals sequence identity with mammalian cell-grown virus. J Virol. 1990 Apr;64(4):1808–1811. doi: 10.1128/jvi.64.4.1808-1811.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Keil W., Geyer R., Dabrowski J., Dabrowski U., Niemann H., Stirm S., Klenk H. D. Carbohydrates of influenza virus. Structural elucidation of the individual glycans of the FPV hemagglutinin by two-dimensional 1H n.m.r. and methylation analysis. EMBO J. 1985 Oct;4(10):2711–2720. doi: 10.1002/j.1460-2075.1985.tb03991.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Klenk H. D., Garten W. Host cell proteases controlling virus pathogenicity. Trends Microbiol. 1994 Feb;2(2):39–43. doi: 10.1016/0966-842x(94)90123-6. [DOI] [PubMed] [Google Scholar]
  11. Moonen P., Mermod J. J., Ernst J. F., Hirschi M., DeLamarter J. F. Increased biological activity of deglycosylated recombinant human granulocyte/macrophage colony-stimulating factor produced by yeast or animal cells. Proc Natl Acad Sci U S A. 1987 Jul;84(13):4428–4431. doi: 10.1073/pnas.84.13.4428. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Munk K., Pritzer E., Kretzschmar E., Gutte B., Garten W., Klenk H. D. Carbohydrate masking of an antigenic epitope of influenza virus haemagglutinin independent of oligosaccharide size. Glycobiology. 1992 Jun;2(3):233–240. doi: 10.1093/glycob/2.3.233. [DOI] [PubMed] [Google Scholar]
  13. Ohuchi M., Cramer A., Vey M., Ohuchi R., Garten W., Klenk H. D. Rescue of vector-expressed fowl plague virus hemagglutinin in biologically active form by acidotropic agents and coexpressed M2 protein. J Virol. 1994 Feb;68(2):920–926. doi: 10.1128/jvi.68.2.920-926.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Ohuchi M., Feldmann A., Ohuchi R., Klenk H. D. Neuraminidase is essential for fowl plague virus hemagglutinin to show hemagglutinating activity. Virology. 1995 Sep 10;212(1):77–83. doi: 10.1006/viro.1995.1455. [DOI] [PubMed] [Google Scholar]
  15. Ohuchi M., Orlich M., Ohuchi R., Simpson B. E., Garten W., Klenk H. D., Rott R. Mutations at the cleavage site of the hemagglutinin after the pathogenicity of influenza virus A/chick/Penn/83 (H5N2). Virology. 1989 Feb;168(2):274–280. doi: 10.1016/0042-6822(89)90267-5. [DOI] [PubMed] [Google Scholar]
  16. Ohuchi R., Ohuchi M., Garten W., Klenk H. D. Human influenza virus hemagglutinin with high sensitivity to proteolytic activation. J Virol. 1991 Jul;65(7):3530–3537. doi: 10.1128/jvi.65.7.3530-3537.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Ohuchi R., Ohuchi M., Garten W., Klenk H. D. Oligosaccharides in the stem region maintain the influenza virus hemagglutinin in the metastable form required for fusion activity. J Virol. 1997 May;71(5):3719–3725. doi: 10.1128/jvi.71.5.3719-3725.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Okamoto M., Nakai M., Nakayama C., Yanagi H., Matsui H., Noguchi H., Namiki M., Sakai J., Kadota K., Fukui M. Purification and characterization of three forms of differently glycosylated recombinant human granulocyte-macrophage colony-stimulating factor. Arch Biochem Biophys. 1991 May 1;286(2):562–568. doi: 10.1016/0003-9861(91)90080-3. [DOI] [PubMed] [Google Scholar]
  19. Oxford J. S., Schild G. C., Corcoran T., Newman R., Major D., Robertson J., Bootman J., Higgins P., al-Nakib W., Tyrrell D. A. A host-cell-selected variant of influenza B virus with a single nucleotide substitution in HA affecting a potential glycosylation site was attenuated in virulence for volunteers. Arch Virol. 1990;110(1-2):37–46. doi: 10.1007/BF01310701. [DOI] [PubMed] [Google Scholar]
  20. Parekh R. B., Dwek R. A., Rudd P. M., Thomas J. R., Rademacher T. W., Warren T., Wun T. C., Hebert B., Reitz B., Palmier M. N-glycosylation and in vitro enzymatic activity of human recombinant tissue plasminogen activator expressed in Chinese hamster ovary cells and a murine cell line. Biochemistry. 1989 Sep 19;28(19):7670–7679. doi: 10.1021/bi00445a023. [DOI] [PubMed] [Google Scholar]
  21. Robertson J. S., Bootman J. S., Newman R., Oxford J. S., Daniels R. S., Webster R. G., Schild G. C. Structural changes in the haemagglutinin which accompany egg adaptation of an influenza A(H1N1) virus. Virology. 1987 Sep;160(1):31–37. doi: 10.1016/0042-6822(87)90040-7. [DOI] [PubMed] [Google Scholar]
  22. Robertson J. S., Naeve C. W., Webster R. G., Bootman J. S., Newman R., Schild G. C. Alterations in the hemagglutinin associated with adaptation of influenza B virus to growth in eggs. Virology. 1985 May;143(1):166–174. doi: 10.1016/0042-6822(85)90105-9. [DOI] [PubMed] [Google Scholar]
  23. Robertson J. S., Nicolson C., Bootman J. S., Major D., Robertson E. W., Wood J. M. Sequence analysis of the haemagglutinin (HA) of influenza A (H1N1) viruses present in clinical material and comparison with the HA of laboratory-derived virus. J Gen Virol. 1991 Nov;72(Pt 11):2671–2677. doi: 10.1099/0022-1317-72-11-2671. [DOI] [PubMed] [Google Scholar]
  24. Seidel W., Künkel F., Geisler B., Garten W., Herrmann B., Döhner L., Klenk H. D. Intraepidemic variants of influenza virus H3 hemagglutinin differing in the number of carbohydrate side chains. Arch Virol. 1991;120(3-4):289–296. doi: 10.1007/BF01310484. [DOI] [PubMed] [Google Scholar]
  25. Sivasubramanian N., Nayak D. P. Mutational analysis of the signal-anchor domain of influenza virus neuraminidase. Proc Natl Acad Sci U S A. 1987 Jan;84(1):1–5. doi: 10.1073/pnas.84.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Skehel J. J., Stevens D. J., Daniels R. S., Douglas A. R., Knossow M., Wilson I. A., Wiley D. C. A carbohydrate side chain on hemagglutinins of Hong Kong influenza viruses inhibits recognition by a monoclonal antibody. Proc Natl Acad Sci U S A. 1984 Mar;81(6):1779–1783. doi: 10.1073/pnas.81.6.1779. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Takeuchi K., Lamb R. A. Influenza virus M2 protein ion channel activity stabilizes the native form of fowl plague virus hemagglutinin during intracellular transport. J Virol. 1994 Feb;68(2):911–919. doi: 10.1128/jvi.68.2.911-919.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Varki A. Biological roles of oligosaccharides: all of the theories are correct. Glycobiology. 1993 Apr;3(2):97–130. doi: 10.1093/glycob/3.2.97. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Wang M. L., Katz J. M., Webster R. G. Extensive heterogeneity in the hemagglutinin of egg-grown influenza viruses from different patients. Virology. 1989 Jul;171(1):275–279. doi: 10.1016/0042-6822(89)90538-2. [DOI] [PubMed] [Google Scholar]
  30. Wilhelm J., Kalyan N. K., Lee S. G., Hum W. T., Rappaport R., Hung P. P. Deglycosylation increases the fibrinolytic activity of a deletion mutant of tissue-type plasminogen activator. Thromb Haemost. 1990 Jun 28;63(3):464–471. [PubMed] [Google Scholar]
  31. Wilson I. A., Skehel J. J., Wiley D. C. Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution. Nature. 1981 Jan 29;289(5796):366–373. doi: 10.1038/289366a0. [DOI] [PubMed] [Google Scholar]
  32. Wittwer A. J., Howard S. C., Carr L. S., Harakas N. K., Feder J., Parekh R. B., Rudd P. M., Dwek R. A., Rademacher T. W. Effects of N-glycosylation on in vitro activity of Bowes melanoma and human colon fibroblast derived tissue plasminogen activator. Biochemistry. 1989 Sep 19;28(19):7662–7669. doi: 10.1021/bi00445a022. [DOI] [PubMed] [Google Scholar]
  33. Wittwer A. J., Howard S. C. Glycosylation at Asn-184 inhibits the conversion of single-chain to two-chain tissue-type plasminogen activator by plasmin. Biochemistry. 1990 May 1;29(17):4175–4180. doi: 10.1021/bi00469a021. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES